Durvalumab vs Metronidazole

## Durvalumab vs Metronidazole: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Metronidazole**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Metronidazole**: Forms cytotoxic free radicals that damage bacterial DNA.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Metronidazole — 8 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Metronidazole — C6H9N3O3.

**Molecular Weight**: Durvalumab — N/A; Metronidazole — 171.1540 g/mol.

**Type**: Durvalumab — Antibody; Metronidazole — Small molecule.